Salem Enrique T, director at DocuSign Inc . (NASDAQ: ), recently sold 10,000 shares of the company’s common stock. The shares were sold at a weighted average price of $91,561, for a total transaction value of $915,610. This transaction was completed on January 10, 2025.
In addition to the sale, Enrique T. Salem also exercised options to acquire 10,000 shares of DocuSign common stock at a price of $13.43 per share. This exercise of the options, however, did not result in the ownership of additional shares after the transaction, as the acquired shares were subsequently sold.
After these transactions, Salem holds 162,265 shares of DocuSign stock. The sale was made in multiple transactions at prices ranging from $91.55 to $91.60 per share.
In other recent news, Docusign Inc. posted a significant performance in its most recent financial quarter, reporting significant gains in revenue, margins and collections. Several analyst firms, including Baird, UBS and Piper Sandler, adjusted their outlook for the company, raising their price targets while maintaining neutral ratings. These revisions follow the successful implementation of Docusign’s Identity Authentication Management (IAM) product, which is still in its early stages but is showing promising initial demand.
Meanwhile, Atlassian (NASDAQ: ) Corporation reported a strong start to fiscal 2025, with a 31% increase in cloud revenue, driven primarily by the successful integration of AI capabilities into its cloud platform. Macquarie initiated coverage on Atlassian with a Neutral rating, citing a balance of positive and negative risks to the company’s outlook.
These are recent events that highlight the financial health and market position of Docusign Inc. and Atlassian Corporation. Analyst firms such as Piper Sandler and RBC Capital Markets provided insight into the companies’ performance, highlighting the importance of revenue growth and the potential for new product offerings.
This article was generated with the support of artificial intelligence and reviewed by an editor. See our T&C for more information.
